Calamos Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $42.2M | Sell |
1,753,548
-52,111
| -3% | -$1.36M | 0.14% | 152 |
|
|
2026
Q1 | $50.7M | Sell |
1,805,659
-113,617
| -6% | -$3.02M | 0.18% | 129 |
|
|
2025
Q4 | $47.8M | Buy |
1,919,276
+58,944
| +3% | +$1.49M | 0.18% | 131 |
|
|
2025
Q3 | $47.4M | Hold |
1,860,332
| – | – | 0.18% | 129 |
|
|
2025
Q2 | $45.1M | Buy |
1,860,332
+83,966
| +5% | +$1.96M | 0.18% | 130 |
|
|
2025
Q1 | $45M | Buy |
1,776,366
+133,792
| +8% | +$3.5M | 0.2% | 122 |
|
|
2024
Q4 | $43.6M | Buy |
1,642,574
+677,341
| +70% | +$18.4M | 0.18% | 126 |
|
|
2024
Q3 | $27.9M | Sell |
965,233
-23,682
| -2% | -$691K | 0.12% | 205 |
|
|
2024
Q2 | $27.7M | Sell |
988,915
-359,419
| -27% | -$9.9M | 0.12% | 199 |
|
|
2024
Q1 | $37.4M | Sell |
1,348,334
-24,942
| -2% | -$692K | 0.18% | 151 |
|
|
2023
Q4 | $39.5M | Sell |
1,373,276
-11,354
| -0.8% | -$343K | 0.19% | 143 |
|
|
2023
Q3 | $45.9M | Buy |
1,384,630
+1,288
| +0.1% | +$45.5K | 0.24% | 106 |
|
|
2023
Q2 | $50.7M | Buy |
1,383,342
+662
| +0% | +$25.8K | 0.25% | 98 |
|
|
2023
Q1 | $56.4M | Sell |
1,382,680
-132,472
| -9% | -$5.72M | 0.28% | 88 |
|
|
2022
Q4 | $77.6M | Sell |
1,515,152
-210,709
| -12% | -$10.1M | 0.36% | 53 |
|
|
2022
Q3 | $75.5M | Sell |
1,725,861
-137,558
| -7% | -$6.68M | 0.35% | 52 |
|
|
2022
Q2 | $97.7M | Buy |
1,863,419
+130,641
| +8% | +$6.66M | 0.42% | 38 |
|
|
2022
Q1 | $89.7M | Buy |
1,732,778
+182,747
| +12% | +$9.48M | 0.34% | 56 |
|
|
2021
Q4 | $91.5M | Sell |
1,550,031
-17,159
| -1% | -$850K | 0.34% | 58 |
|
|
2021
Q3 | $67.4M | Buy |
1,567,190
+177,387
| +13% | +$7.86M | 0.29% | 79 |
|
|
2021
Q2 | $54.4M | Buy |
1,389,803
+249,928
| +22% | +$9.72M | 0.25% | 93 |
|
|
2021
Q1 | $41.3M | Buy |
1,139,875
+26,243
| +2% | +$932K | 0.23% | 110 |
|
|
2020
Q4 | $41M | Sell |
1,113,632
-98,242
| -8% | -$3.6M | 0.24% | 113 |
|
|
2020
Q3 | $42.2M | Sell |
1,211,874
-272,336
| -18% | -$9.55M | 0.27% | 91 |
|
|
2020
Q2 | $46M | Sell |
1,484,210
-63,670
| -4% | -$2.16M | 0.33% | 81 |
|
|
2020
Q1 | $47.9M | Sell |
1,547,880
-2,033,943
| -57% | -$69.3M | 0.38% | 66 |
|
|
2019
Q4 | $133M | Buy |
3,581,823
+150,185
| +4% | +$5.35M | 0.66% | 21 |
|
|
2019
Q3 | $117M | Sell |
3,431,638
-118,270
| -3% | -$4.3M | 0.64% | 28 |
|
|
2019
Q2 | $146M | Buy |
3,549,908
+508,638
| +17% | +$20.2M | 0.81% | 17 |
|
|
2019
Q1 | $123M | Buy |
3,041,270
+721,453
| +31% | +$28.9M | 0.76% | 14 |
|
|
2018
Q4 | $96.1M | Buy |
2,319,817
+142,846
| +7% | +$5.93M | 0.63% | 25 |
|
|
2018
Q3 | $91M | Sell |
2,176,971
-53,423
| -2% | -$2.06M | 0.5% | 39 |
|
|
2018
Q2 | $76.8M | Buy |
2,230,394
+107,767
| +5% | +$3.68M | 0.47% | 40 |
|
|
2018
Q1 | $71.5M | Buy |
2,122,627
+31,197
| +1% | +$1.07M | 0.47% | 43 |
|
|
2017
Q4 | $71.9M | Sell |
2,091,430
-47,979
| -2% | -$1.64M | 0.37% | 43 |
|
|
2017
Q3 | $72.5M | Buy |
2,139,409
+29,301
| +1% | +$942K | 0.56% | 33 |
|
|
2017
Q2 | $67.2M | Sell |
2,110,108
-153,501
| -7% | -$4.84M | 0.5% | 45 |
|
|
2017
Q1 | $73.5M | Sell |
2,263,609
-726,420
| -24% | -$22.9M | 0.58% | 38 |
|
|
2016
Q4 | $92.1M | Sell |
2,990,029
-6,266
| -0.2% | -$191K | 0.73% | 25 |
|
|
2016
Q3 | $96.3M | Sell |
2,996,295
-6,313
| -0.2% | -$211K | 0.69% | 26 |
|
|
2016
Q2 | $100M | Sell |
3,002,608
-7,356
| -0.2% | -$235K | 0.7% | 23 |
|
|
2016
Q1 | $84.6M | Buy |
3,009,964
+46,080
| +2% | +$1.32M | 0.56% | 36 |
|
|
2015
Q4 | $90.8M | Buy |
2,963,884
+12,285
| +0.4% | +$386K | 0.58% | 37 |
|
|
2015
Q3 | $88M | Sell |
2,951,599
-13,345
| -0.5% | -$428K | 0.61% | 34 |
|
|
2015
Q2 | $94.3M | Sell |
2,964,944
-51,674
| -2% | -$1.68M | 0.58% | 38 |
|
|
2015
Q1 | $99.6M | Buy |
3,016,618
+294,192
| +11% | +$9.35M | 0.62% | 30 |
|
|
2014
Q4 | $80.5M | Buy |
2,722,426
+639,838
| +31% | +$18.3M | 0.53% | 52 |
|
|
2014
Q3 | $58.4M | Sell |
2,082,588
-185
| -0% | -$5.19K | 0.39% | 69 |
|
|
2014
Q2 | $58.6M | Buy |
2,082,773
+52,780
| +3% | +$1.5M | 0.37% | 76 |
|
|
2014
Q1 | $61.9M | Hold |
2,029,993
| – | – | 0.4% | 70 |
|
|
2013
Q4 | $59M | Sell |
2,029,993
-211,860
| -9% | -$6.17M | 0.38% | 66 |
|
|
2013
Q3 | $61.1M | Sell |
2,241,853
-1,799,083
| -45% | -$49M | 0.38% | 67 |
|
|
2013
Q2 | $107M | Buy |
+4,040,936
| New | +$112M | 0.7% | 32 |
|
Other funds holding PFE
Calamos Advisors's PFE Position: Q2 2026 in Review
Calamos Advisors reduced its Pfizer (PFE) stake by 2.9% in Q2 2026, selling an estimated $1.36M and leaving 1,753,548 shares worth $42.2M. The position accounts for 0.14% of the portfolio, ranked #152.
Calamos Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $146M in Q2 2019. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Calamos Advisors held 1,753,548 shares of Pfizer worth $42.2M as of Q2 2026.
- Calamos Advisors sold 52,111 Pfizer shares in Q2 2026, an estimated $1.36M.
- Pfizer made up 0.14% of Calamos Advisors's portfolio in Q2 2026, its #152 holding.
- Calamos Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Calamos Advisors's Pfizer position peaked at $146M in Q2 2019.
- 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.